From its emergence to the present day, the Blue Scorpion Venom , has gone through different stages. Throughout this article we will review its evolution, going from its empirical beginnings to become a subject of study and debate in the medical-scientific field, which makes it one of the most effective natural treatments to treat the following diseases: diabetes. cancer.

BORDIER STAGE (1980-2005).

The term Escozul ®was first used in the 1980s. Combine two words: Scorpion ( Esco) and Blue ( Zul). Refers to a natural product derived from Blue Scorpion Venom , scientifically known as Rhopalurus Junceus species that only inhabits the Caribbean Island: Cuba.

The biologist Misael Bordier was the discoverer of the medicinal properties of the Blue Scorpion Venom . His experiments on rats and dogs, afflicted with cancerous tumors, yielded impressive results, especially in tumor reduction. This work, Bordier He continued it at the University of Medical Sciences of Guantanamo, and in the 1990s, he began to administer the solution to human patients, who also showed a reduction of malignant cells and a drastic prolongation of survival time.

In 2005, Misael Bordierdied without being able to publish scientific studies due to the limitations of his time. Su patente fue cancelada y en los últimos años de vida el accionar de Bordier The company limited itself to experimenting empirically with the handmade formulation.

However, these circumstances do not minimize or deny the merit of being the first one to discover the medicinal benefits of the Blue Scorpion Venom and be an inspiration for further research.

STAGE Labiofam (2005-2009).

Beginning in 2005 and continuing through 2009, LABIOFAM made its first attempts to use the Blue Scorpion Venom . However, the company decided to make an about-face in favor of the homeopathic product. Vidatox 30CH. This fact was highly criticized by Cuban scientists. See what the scientific community thinks about Vidatox.

LABIOFAM opted for a homeopathic variant due to the low cost of production and the lack of requirements necessary for product registration. These characteristics, together with the fact that clinical trials and scientific tests are not necessary, were attractive from an economic point of view.

STAGE LIFESCOZUL® (2009 – PRESENT).

After the change given by LABIOFAM, the biologist graduated from the University of Havana, Ariel Portal member of the project Escozul®. founds the LifEscozul® Group in 2009 with the objective of deepening the studies on the therapeutic properties of the Blue Scorpion Venom®.

The LifEscozul® Group, is the exclusive owner of the trademark Escozul®. ( See trademark registration), as well as tangible results in oncology patients who have taken the Blue Scorpion Venom (See Results).

Over the past few years, the prestigious Dr. Alexis Diaz joined the Team of Scientists that investigate the properties of the Blue Scorpion Venom in the LifEscozul® Group . The Dr. Diaz is currently leading the Research and Development Department at LifEscozul® Group. He also has an extensive academic curriculum with 17 years of experience and 25 articles published on the subject. Blue Scorpion Venom. See articles.

The Dr. Mariela Guevara, also integrates the LifEscozul® Work Team as an expert in the area of Clinical Trials. With more than a decade dedicated to protocol management with rehearsals, the Dra. Guevara,directs the necessary documentation tasks and their measurable evaluation.

The LifEscozul® Group, has a Professional Team highly qualified, integrated by physicians, biochemists, biologists and nutritionists, recognized not only for their excellent preparation but also for their human warmth so important in patient care.

See Specialists.

We also see patients with arthritis and lupus due to the anti-inflammatory effect of .Blue Scorpion Venom proven in scientific studies. See study

During the last few years, research with high academic rigor has demonstrated the antitumor properties in the Blue Scorpion Venom .This has been possible thanks to the rigorous research work carried out by the Dr. Alexis Diaz. Relevant scientific publications such as the Frontiers Magazine have disseminated their articles on this subject.

The following are some of the most important ones:

June 2013.

In vitro anti-cancer effect of the venom of the Cuban scorpion Rhopalurus junceus against a panel of human cancer cell lines.

In this study, it was found that the Blue Scorpion Venom In addition, it induces the death of the less sensitive tumor cells, has a selective and differential toxicity against the cancer cells epithelials.

April, 2017.

Rhopalurus Junceus scorpion venom induces Apoptosis in the triple-negative human breast cancer cell line MDA-MB-231.

Through this research it was confirmed that the Blue Scorpion Venom , induces cell death in Triple Negative Breast Cancer highly invasive.

September, 2018.

Effect of Rhopalurus Junceus scorpion venom on inflammation-related cytokines in healthy BALB/C mice.

It was corroborated that when administering a single dose of the Blue Scorpion Venom , levels of proinflammatory cytokines do not increase. In other words, it means that the Blue Scorpion Venom prevents inflammation.

January, 2019.

Synergistic effect of Rhopalurus Junceus scorpion venom combined with conventional cytostatics on the cervical cancer cell line hela.

It is concluded that the Blue Scorpion Venom , reduces the viability of the cancer cells epithelial cells and has a negligible cytotoxic effect on normal cells.

June, 2020.

Voltage-activated K+/NA+ channels and scorpion venom toxins in cancer.

It was again found that the Blue Scorpion Venom , does not cause toxic effects by oral administration. In addition, a decrease in tumor progression was demonstrated in mice carrying breast tumors, which once again demonstrates the antitumor effect of the Blue Scorpion Venom ®.

At this time the Research and Development Department is proudly involved in a series of scientific agreements for the development of the sanitary registry, among which the following stand out Universidad de Chile; Universidad Talca in Chile; Laboratorios Salimax also located in this South American country.

In addition, there are other centers such as the Pharmometrica Laboratories located in Mexico next to Research Pro SC Mexican company and to the Tecnológico Monterrey.

Another of the research projects is focused on synthesizing the .Blue Scorpion Venom by identifying the key components in its active ingredient. The first two phases of toxicological studies required prior to conducting the studies have been successfully completed. Clinical Trials and the regulatory framework to evaluate the effectiveness of the Escozul Formulation ®.